ye-public-hai-sab-jaanti-hai
  1. You Are At:
  2. English News
  3. India
  4. Bharat Biotech's Covaxin added to approved list of COVID vaccines for travel to Australia

Bharat Biotech's Covaxin added to approved list of COVID vaccines for travel to Australia

Meanwhile, Covaxin is yet to receive approval from the World Health Organisation, which last week said it expects to receive clarifications from Bharat Biotech.

India TV News Desk Edited by: India TV News Desk
New Delhi Updated on: November 01, 2021 13:01 IST
covaxin
Image Source : PTI

Australian Government recognises Bharat Biotech's Covaxin for the purpose of establishing a traveller's vaccination status

The Australian government on Monday gave recognition to Bharat Biotech's Covaxin COVID-19 vaccine for the purpose of establishing a traveller's vaccination status in the country.

"Today, the Therapeutic Goods Administration determined that Covaxin (manufactured by BharatBiotech) vaccine would be 'recognised' for the purpose of establishing a traveller's vaccination status," Australia's High Commissioner to India Barry O'Farrell informed in a tweet.

"Importantly, recognition of Covaxin, along with the previously announced recognition of Covishield (manufactured by AstraZeneca India, means many citizens, as well as other countries, will now be considered fully vaccinated on entry to Australia," the High Commissioner added.

COVID-19 vaccines are approved for use in Australia by the Therapeutic Goods Administration (TGA) after an assessment and approval process.

"In recent weeks, the TGA has obtained additional information demonstrating these vaccines provide protection and potentially reduce the likelihood that an incoming traveller would transmit COVID-19 infection to others while in Australia or become acutely unwell due to COVID-19," a statement from Australia's Department of Health informed.

Recognition of Covaxin, along with the previously announced recognition of Covishield (manufactured by AstraZeneca, India), means many citizens of India, as well as other countries where these vaccines have been widely deployed, will now be considered fully vaccinated on entry to Australia, the statement said.

"This will have significant impacts for the return of international students, and travel of skilled and unskilled workers to Australia," the statement added.

From 1 November 2021, vaccinated Australians and permanent residents aged 12 and over may depart Australia without the need to seek a travel exemption, the Australian Health Department said.

Covaxin still awaits WHO approval

Meanwhile, Covaxin is yet to receive approval from the World Health Organisation, which last week said it expects to receive clarifications from Bharat Biotech. The health agency said it would meet on November 3 for a final risk-benefit assessment for the Emergency Use Listing.

“WHO Technical Advisory Group for Emergency Use Listing (EUL) is an independent advisory group that provides recommendations to WHO on whether a #COVID19 vaccine can be listed for emergency use under the EUL procedure,” the WHO tweeted.

The Technical Advisory Group met on October 26 and “decided that additional clarifications from the manufacturer (Bharat Biotech) are needed to conduct a final EUL risk-benefit assessment for global use of the Covaxin vaccine".

Also Read | WHO denies approval to Bharat Biotech's Covaxin

Latest India News

Write a comment